STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $104,000 | -1.9% | 6,800 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $106,000 | -87.6% | 6,800 | -91.4% | 0.00% | -83.3% |
Q3 2016 | $852,000 | -27.7% | 78,679 | -54.8% | 0.01% | -25.0% |
Q2 2016 | $1,179,000 | +45.2% | 174,179 | 0.0% | 0.01% | +60.0% |
Q1 2016 | $812,000 | -19.1% | 174,179 | +9.4% | 0.01% | -16.7% |
Q4 2015 | $1,004,000 | +198.8% | 159,179 | +318.9% | 0.01% | +200.0% |
Q3 2015 | $336,000 | – | 38,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |